<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198324</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2019/94</org_study_id>
    <nct_id>NCT04198324</nct_id>
  </id_info>
  <brief_title>Isthmocele After Endometrial and Non-endometrial Suturing in Cesarean Section</brief_title>
  <official_title>Isthmocele After Endometrial and Non-endometrial Suturing in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the effect of two techniques of uterine closure, with or without
      endometrial suturing on isthmocele development after cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean section is the most common surgery performed on pregnant women. Poor healing of the
      incision of the uterus leads to isthmocele development. Long-term morbidities associated with
      isthmocele are uterine scar pregnancy, uterine perforation, pelvic pain, and spotting-style
      bleeding after menstruation. Many factors that may affect the healing of uterine scar have
      been studied in the literature (i.e. Double or single-layer closure, locked or unlocked
      closure, uterine retroflection). Suturing complete fold of the wound lips during the closure
      of the uterus may cause the endometrial layer to be embedded in the myometrium and to form
      niche tissue. The study hypothesized that isthmocele development can be reduced by suturing
      without enclosing the endometrium during uterine closure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Closure of the hysterotomy at the time of primary cesarean section</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with isthmocele six month after cesarean section</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>Residual myometrium thickness of less then 2.5 mm with transvaginal ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean myometrium thickness</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>Myometrial thickness measured at incision site with transvaginal ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spotting</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>The rate of spotting complains of patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Cesarean Section; Dehiscence</condition>
  <condition>Cesarean Wound; Dehiscence</condition>
  <arm_group>
    <arm_group_label>Entire fold uterine closure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The uterus will be sewn with full fold locked sutures that pass through myometrium and endometrium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-endometrial uterine closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The uterus will be sewn with locked sutures that pass through myometrium without endometrium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Closure of the uterus with endometrium at the time of cesarean</intervention_name>
    <description>Closure of the uterus at the time of primary cesarean will be performed with suturing the endometrium.</description>
    <arm_group_label>Entire fold uterine closure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Closure of the uterus without endometrium at the time of cesarean</intervention_name>
    <description>Closure of the uterus at the time of primary cesarean will be performed without suturing the endometrium.</description>
    <arm_group_label>Non-endometrial uterine closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term pregnancy (≥37 weeks of gestation)

          -  Singleton pregnancy

          -  Primary cesarean

        Exclusion Criteria:

          -  Previous cesarean section

          -  Previous uterine surgery

          -  Multiple gestations

          -  Mullerian anomalies

          -  Active labor

          -  Placenta previa/accreta
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Şener Gezer, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Şener Gezer, M.D</last_name>
    <phone>+902623037039</phone>
    <email>dr.senergezer@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kocaeli University</name>
      <address>
        <city>Kocaeli</city>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Şener Gezer</last_name>
      <phone>2623037039</phone>
      <email>dr.senergezer@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Bij de Vaate AJ, van der Voet LF, Naji O, Witmer M, Veersema S, Brölmann HA, Bourne T, Huirne JA. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372-82. doi: 10.1002/uog.13199. Review.</citation>
    <PMID>23996650</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>December 16, 2019</last_update_submitted>
  <last_update_submitted_qc>December 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Şener Gezer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

